ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

XAIR Beyond Air Inc

1.3498
0.0398 (3.04%)
Jun 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 312,131
Bid Price 1.26
Ask Price 1.34
News (1)
Day High 1.34

Low
1.06

52 Week Range

High
6.36

Day Low 1.25
Company Name Stock Ticker Symbol Market Type
Beyond Air Inc XAIR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0398 3.04% 1.3498 19:50:01
Open Price Low Price High Price Close Price Prev Close
1.28 1.25 1.34 1.26 1.31
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,609 312,131 $ 1.30 $ 406,907 - 1.06 - 6.36
Last Trade Time Type Quantity Stock Price Currency
19:36:15 1 $ 1.33 USD

Beyond Air Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
45.41M 36.04M - 0 -55.82M -1.55 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Beyond Air News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No XAIR Message Board. Create One! See More Posts on XAIR Message Board See More Message Board Posts

Historical XAIR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.261.351.201.27244,6320.08987.13%
1 Month1.311.351.061.20303,1520.03983.04%
3 Months1.731.781.061.26316,676-0.3802-21.98%
6 Months1.572.35991.061.60384,000-0.2202-14.03%
1 Year6.126.361.062.44418,061-4.77-77.94%
3 Years5.3216.411.066.17392,990-3.97-74.63%
5 Years5.6516.411.066.25345,195-4.30-76.11%

Beyond Air Description

Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company which develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Your Recent History

Delayed Upgrade Clock